Diabetes Drugs

Mungaro, their diabetes drug is so closely watched and it actually came in a little bit short of expectations in the fourth quarter. Dave Ricks was just talking about how incredible this launch has been for them and how fast it's going. You know, it's interesting because there's been so much demand for these medicines that there have been supply constraints. They haven't been able to manufacture as much.